TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Rathinam, Vijay A. K.Vanaja, Sivapriya Kailasan
Waggoner, Lisa
Sokolovska, Anna
Becker, Christine
Stuart, Lynda M.
Leong, John M.
Fitzgerald, Katherine A
UMass Chan Affiliations
Department of Medicine, Division of Infectious Diseases and ImmunologyDocument Type
Journal ArticlePublication Date
2012-08-03Keywords
Adaptor Proteins, Vesicular TransportAnimals
Carrier Proteins
Caspases
Citrobacter rodentium
Enterohemorrhagic Escherichia coli
Gram-Negative Bacteria
Gram-Positive Bacteria
Inflammasomes
Interferons
Mice
Signal Transduction
Immunology and Infectious Disease
Metadata
Show full item recordAbstract
Systemic infections with Gram-negative bacteria are characterized by high mortality rates due to the "sepsis syndrome," a widespread and uncontrolled inflammatory response. Though it is well recognized that the immune response during Gram-negative bacterial infection is initiated after the recognition of endotoxin by Toll-like receptor 4, the molecular mechanisms underlying the detrimental inflammatory response during Gram-negative bacteremia remain poorly defined. Here, we identify a TRIF pathway that licenses NLRP3 inflammasome activation by all Gram-negative bacteria. By engaging TRIF, Gram-negative bacteria activate caspase-11. TRIF activates caspase-11 via type I IFN signaling, an event that is both necessary and sufficient for caspase-11 induction and autoactivation. Caspase-11 subsequently synergizes with the assembled NLRP3 inflammasome to regulate caspase-1 activation and leads to caspase-1-independent cell death. These events occur specifically during infection with Gram-negative, but not Gram-positive, bacteria. The identification of TRIF as a regulator of caspase-11 underscores the importance of TLRs as master regulators of inflammasomes during Gram-negative bacterial infection.Source
Cell. 2012 Aug 3;150(3):606-19. doi: 10.1016/j.cell.2012.07.007. Link to article on publisher's siteDOI
10.1016/j.cell.2012.07.007Permanent Link to this Item
http://hdl.handle.net/20.500.14038/34918PubMed ID
22819539Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1016/j.cell.2012.07.007